Research finds inactivation of brain region normalizes blood pressure in hypertensive individuals — Evidence Review
Published in Circulation Research, by researchers from Manaaki Manawa, Centre for Heart Research at Waipapa Taumata Rau, University of Auckland
Table of Contents
Researchers at the University of Auckland have identified a specific brainstem region, the lateral parafacial region, as a key driver of high blood pressure, and showed that its inactivation can normalize blood pressure in hypertensive subjects. Existing literature generally agrees that the brain plays a central role in blood pressure regulation, though most prior studies have focused on other brain areas and mechanisms.
- The new study expands on previous research that has already linked various brain regions (such as the rostral ventrolateral medulla and paraventricular nucleus) and neuroinflammatory processes to neurogenic forms of hypertension, reinforcing the importance of central nervous system involvement in blood pressure control 1 3 4 5.
- Unlike earlier research that highlighted microglial activation, RAAS pathways, and the role of sodium channels in hypertension, this study identifies a previously unrecognized region (the lateral parafacial region) and connects it to forced exhalation and sympathetic vascular control, suggesting a novel mechanism 1 4 5.
- The findings also build on the concept that peripheral signals such as those from carotid bodies can influence central blood pressure regulation, aligning with the broader understanding that multiple brain-periphery feedback loops are involved in hypertension 2 4 5.
Study Overview and Key Findings
Hypertension, or high blood pressure, affects millions worldwide and is a leading risk factor for cardiovascular disease. While the brain’s involvement in blood pressure regulation is well established, most research has focused on classic regions such as the hypothalamus and medulla or on neurohormonal pathways. This study is significant as it identifies the lateral parafacial region—a brainstem area not previously linked to hypertension—as a key player in controlling blood pressure, particularly through its connections to forced abdominal breathing and vascular sympathetic output. The discovery also opens avenues for targeting peripheral sensors, like the carotid bodies, for therapeutic intervention, which may have fewer side effects than central nervous system drugs.
| Property | Value |
|---|---|
| Organization | Manaaki Manawa, Centre for Heart Research at Waipapa Taumata Rau, University of Auckland |
| Journal Name | Circulation Research |
| Authors | Professor Julian Paton |
| Population | People with hypertension |
| Outcome | Blood pressure levels, brain activation patterns |
| Results | Inactivating the lateral parafacial region normalized blood pressure. |
Literature Review: Related Studies
We searched the Consensus paper database, which contains over 200 million research papers, to identify related studies on brain mechanisms and blood pressure regulation. The following search queries were used:
- lateral parafacial region blood pressure
- brain mechanisms hypertension regulation
- blood pressure normalization techniques
Literature Review Table
| Topic | Key Findings |
|---|---|
| How does the brain regulate blood pressure and contribute to hypertension? | - Microglia-driven neuroinflammation increases sympathetic tone and contributes to hypertension 1. - Central neural circuits (esp. rostral ventrolateral medulla) mediate neurogenic hypertension via increased sympathetic drive 5. |
| What are the roles of specific brain regions and molecular pathways in blood pressure regulation? | - Paraventricular nucleus and associated signaling proteins (e.g., Gai2, ACE2, ADAM17) modulate neuronal excitation and blood pressure 2 3. - The Na(+)-ENaC-RAAS-EDLF axis in the brain is crucial for sympathetic outflow and hypertension 4. |
| What are effective strategies for blood pressure normalization and management? | - Multilevel, multicomponent strategies (team-based care, medication titration) are most effective for BP control 6. - Exercise interventions and novel monitoring technologies (e.g., PPG, cuffless wearables) show promise for BP management 7 9 10. |
| Can peripheral signals or interventions influence central blood pressure regulation? | - Carotid body activity and baroreflex mechanisms influence central control of BP and may be therapeutic targets 2 5. - Peripheral interventions (e.g., vaspin, IGF-1) can affect central regulatory pathways 2. |
How does the brain regulate blood pressure and contribute to hypertension?
Research over the past two decades has established that the central nervous system plays a pivotal role in blood pressure regulation, primarily via sympathetic nervous system outflow. Neuroinflammation, especially involving microglial activation, and heightened excitatory drive in brainstem regions have been implicated in the development and maintenance of hypertension. The new study supports this general framework but identifies a previously unrecognized brainstem area, the lateral parafacial region, adding nuance to the understanding of neurogenic hypertension.
- Microglial activation in the brain leads to neuroinflammation, which increases sympathetic tone and raises blood pressure 1.
- The rostral ventrolateral medulla is a well-established hub for sympathetic vasomotor neuron activity, mediating neurogenic hypertension 5.
- The new findings suggest that the lateral parafacial region acts as an additional node integrating breathing, sympathetic outflow, and vascular tone.
- This study aligns with the consensus that brain-driven mechanisms are key contributors to essential hypertension, expanding the focus beyond previously known regions 1 5.
What are the roles of specific brain regions and molecular pathways in blood pressure regulation?
Several brain regions and molecular pathways—such as the paraventricular nucleus, Gai2 proteins, ACE2/ADAM17 balance, and sodium-driven RAAS activation—have been implicated in blood pressure regulation. The new study adds the lateral parafacial region to this network, particularly in the context of forced breathing and sympathetic nerve activity, suggesting a broader array of central sites and pathways that could be targeted for hypertension therapy.
- The paraventricular nucleus modulates sympathetic outflow and is influenced by neurotrophic factors and Gai2 signaling 2 3.
- ACE2 and ADAM17 interact to balance excitatory and inhibitory presympathetic neuron activity, affecting blood pressure 3.
- High sodium intake activates the brain’s RAAS pathway and epithelial sodium channels, increasing sympathetic drive and contributing to hypertension 4.
- The new findings suggest the lateral parafacial region is another central site with potential for targeted intervention, especially via peripheral modulation (e.g., carotid body activity) 2 4.
What are effective strategies for blood pressure normalization and management?
Traditional hypertension management emphasizes lifestyle changes and pharmacotherapy, but recent research highlights the importance of individualized, multicomponent strategies and novel monitoring approaches. The new study suggests that targeting specific brain or peripheral pathways could complement existing strategies, particularly for patients with neurogenic hypertension.
- Team-based care, medication titration, and multilevel interventions are the most effective for achieving blood pressure control 6.
- Exercise programs, especially those designed to be sustainable, are effective in normalizing nocturnal blood pressure patterns and reducing cardiovascular risk 9.
- Novel wearable and cuffless technologies may improve the accuracy and convenience of blood pressure monitoring, aiding early detection and personalized management 7 10.
- The potential to target the lateral parafacial region or carotid bodies pharmacologically may offer new adjunctive therapies for hypertension, though more research is needed 2 6.
Can peripheral signals or interventions influence central blood pressure regulation?
There is increasing recognition that peripheral signals—such as those from the carotid bodies or baroreceptors—can modulate central nervous system control of blood pressure. The new study’s focus on carotid body-mediated activation of the lateral parafacial region aligns with this broader understanding and suggests that peripheral interventions may be a promising therapeutic avenue.
- Carotid body activity, which increases during sleep apnea or hypoxia, can drive central sympathetic outflow and contribute to hypertension 2 5.
- Peripheral therapies, such as vaspin or IGF-1 administration, have demonstrated effects on central blood pressure regulation pathways 2.
- Baroreflex sensitivity and modulation remain important targets for both research and potential therapeutic intervention 5.
- The new study advances this field by proposing that pharmacological targeting of carotid bodies could safely and effectively modulate central blood pressure control without direct brain intervention 2 5.
Future Research Questions
Although this study sheds light on a new brain region involved in hypertension, several important questions remain unanswered. Further research is needed to validate these findings in diverse populations, explore the mechanisms linking forced breathing and sympathetic outflow, and develop targeted therapies that can modulate the newly identified pathways safely and effectively.
| Research Question | Relevance |
|---|---|
| What is the precise mechanism by which the lateral parafacial region influences blood pressure? | Understanding the molecular and neuronal pathways will clarify how this region integrates respiratory and cardiovascular signals, informing targeted interventions 1 3 4. |
| Can pharmacological modulation of the carotid bodies safely reduce blood pressure in humans? | Since the study proposes targeting carotid bodies as a safer alternative to central drugs, clinical trials are needed to assess efficacy and safety in human populations 2 5. |
| How does lateral parafacial region activity vary in different forms of hypertension? | Determining whether this mechanism is specific to certain hypertension phenotypes (e.g., neurogenic, sleep apnea-related) will guide patient selection for targeted therapies 2 9. |
| Does targeting the lateral parafacial region improve hypertension-related cardiovascular outcomes? | It remains to be seen if interventions aimed at this brain region can reduce the long-term risk of stroke, heart failure, and other complications 6 9. |
| What are the interactions between respiratory patterns, autonomic control, and blood pressure regulation? | Since forced abdominal breathing is implicated, deeper investigation into how breathing patterns influence autonomic and blood pressure control could reveal new therapeutic targets 1 5. |